FDA PMA FDA Class 3 Approved 🇺🇸 United States

Catheter, Coronary, Atherectomy

PMA: P900056 · Supplement: S024 · Decision Sep 2, 1998
Classifications
1
FEI Numbers
22
Registration Numbers
22

Basic Information

Device Name
Catheter, Coronary, Atherectomy
Trade Name
ROTABLATOR ROTALINK PLUS ROTATIONAL ANGIOPLASTY SYSTEM
PMA Number
P900056
Supplement Number
S024
Device Class
FDA Class 3
Product Code
MCX
Generic Name
CATHETER, CORONARY, ATHERECTOMY
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
September 2, 1998
Date Received
August 11, 1998
Supplement Type
Real-Time Process
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Approval to provide the Rotablator(R) RotaLink system to the user in a pre-connected configuration. The device, as modified, will be marketed under the trade name Rotoblator(R) RotaLink Plus(TM) Rotational Angioplasty system and is indicated as a means of providng percutaneous rotational coronary angioplasty, as a sole therapy or with adjunctive balloon angioplasty, in patients with coronary artery disease who are candidates for coronary artery bypass graft surgery and who meet one of the following selection criteria: 1) single vessel atherosclerotic coronary artery disease with a stenosis that can be passed with a guide wire; 2) multiple vessel coronary artery disease that in the physician's judgment does not pose undue risk to the patient; 3) certain patients who have had prior percutaneous transluminal coronary angioplasty (PTCA), and who have a restenosis of the native vessel; or 4) native vessel atherosclerotic coronary artery disease that is less than 25mm in length.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MCX Catheter, Coronary, Atherectomy